Michael Dudley

548 total citations
26 papers, 431 citations indexed

About

Michael Dudley is a scholar working on Pharmacology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Michael Dudley has authored 26 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 14 papers in Molecular Medicine and 6 papers in Infectious Diseases. Recurrent topics in Michael Dudley's work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (14 papers) and Antibiotic Use and Resistance (6 papers). Michael Dudley is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (14 papers) and Antibiotic Use and Resistance (6 papers). Michael Dudley collaborates with scholars based in United States, Switzerland and Austria. Michael Dudley's co-authors include Olga Lomovskaya, Debora Rubio-Aparicio, Dongxu Sun, Ruslan Tsivkovski, Kirk Nelson, Maxim Totrov, Robert M. Swift, Paolo B. DePetrillo, Jeffery S. Loutit and David Sanders and has published in prestigious journals such as Scientific Reports, The American Journal of Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael Dudley

24 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Dudley United States 15 223 163 92 85 76 26 431
Marlynne Micalizzi United States 4 230 1.0× 222 1.4× 75 0.8× 44 0.5× 85 1.1× 6 367
Eun-Hwa Choi South Korea 6 243 1.1× 67 0.4× 75 0.8× 88 1.0× 228 3.0× 10 502
Mario Cepparulo Italy 11 137 0.6× 56 0.3× 53 0.6× 46 0.5× 135 1.8× 22 373
Anneke C. Dijkmans Netherlands 8 127 0.6× 96 0.6× 67 0.7× 35 0.4× 117 1.5× 14 313
Chuanqi Wei China 10 264 1.2× 157 1.0× 41 0.4× 76 0.9× 104 1.4× 15 517
V. T. Lolans United States 8 259 1.2× 314 1.9× 62 0.7× 65 0.8× 167 2.2× 10 443
Olle Aspevall Sweden 8 154 0.7× 58 0.4× 69 0.8× 78 0.9× 203 2.7× 12 375
Roopali Sharma United States 7 160 0.7× 66 0.4× 104 1.1× 38 0.4× 69 0.9× 21 367
Jae‐Cheol Kwon South Korea 11 123 0.6× 67 0.4× 202 2.2× 34 0.4× 202 2.7× 21 391
İlknur Erdem Türkiye 9 83 0.4× 35 0.2× 48 0.5× 53 0.6× 109 1.4× 17 274

Countries citing papers authored by Michael Dudley

Since Specialization
Citations

This map shows the geographic impact of Michael Dudley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dudley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dudley more than expected).

Fields of papers citing papers by Michael Dudley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Dudley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dudley. The network helps show where Michael Dudley may publish in the future.

Co-authorship network of co-authors of Michael Dudley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Dudley. A scholar is included among the top collaborators of Michael Dudley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Dudley. Michael Dudley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeitlinger, Markus, et al.. (2024). Communicable Episode 10: Pipeline update on new antibiotics & other antimicrobials. 2(1). 105054–105054.
2.
Lomovskaya, Olga, Mariana Castanheira, Debora Rubio-Aparicio, et al.. (2023). In vitro potency of xeruborbactam in combination with multiple β-lactam antibiotics in comparison with other β-lactam/β-lactamase inhibitor (BLI) combinations against carbapenem-resistant and extended-spectrum β-lactamase-producing Enterobacterales. Antimicrobial Agents and Chemotherapy. 67(11). e0044023–e0044023. 30 indexed citations
3.
Lomovskaya, Olga, et al.. (2023). New boronate drugs and evolving NDM-mediated beta-lactam resistance. Antimicrobial Agents and Chemotherapy. 67(9). e0057923–e0057923. 14 indexed citations
4.
Lomovskaya, Olga, Ruslan Tsivkovski, Dongxu Sun, et al.. (2021). QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics. Frontiers in Microbiology. 12. 697180–697180. 34 indexed citations
5.
6.
Lomovskaya, Olga, Debora Rubio-Aparicio, Kirk Nelson, et al.. (2021). In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 65(6). 21 indexed citations
7.
Nelson, Kirk, Debora Rubio-Aparicio, Dongxu Sun, Michael Dudley, & Olga Lomovskaya. (2020). In Vitro Activity of the Ultrabroad-Spectrum-Beta-Lactamase Inhibitor QPX7728 against Carbapenem-Resistant Enterobacterales with Varying Intrinsic and Acquired Resistance Mechanisms. Antimicrobial Agents and Chemotherapy. 64(8). 37 indexed citations
8.
Moeck, Greg, et al.. (2018). A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program. Open Forum Infectious Diseases. 5(6). ofy051–ofy051. 16 indexed citations
9.
Klinker, Kenneth, et al.. (2018). 1181. Use of the Combination Antibiogram in the Era of MDR Gram-Negative Pathogens. Open Forum Infectious Diseases. 5(suppl_1). S357–S357.
10.
Yoo, Byunghee, Amol Kavishwar, Ping Wang, et al.. (2017). Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer. Scientific Reports. 7(1). 45060–45060. 37 indexed citations
11.
Rubio-Aparicio, Debora, et al.. (2017). Potency of Meropenem-Vaborbactam in Lung Surfactant. Antimicrobial Agents and Chemotherapy. 62(1). 6 indexed citations
12.
Huang, Dennis S., Rajnikant Sharma, Michael Dudley, et al.. (2017). In Vitro Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae. Antimicrobial Agents and Chemotherapy. 61(7). 17 indexed citations
13.
Lomovskaya, Olga, et al.. (2015). Rationale for Dose Selection for Carbavance ([CVC] Meropenem/RPX7009) in Phase 3 Trials. Open Forum Infectious Diseases. 2(suppl_1). 4 indexed citations
14.
Demarest, Stephen J., Mangala J. Hariharan, Jared Salbato, et al.. (2010). Neutralization ofClostridium difficiletoxin A using antibody combinations. mAbs. 2(2). 190–198. 28 indexed citations
15.
Sanders, David, Michael Dudley, & Leanne Groban. (2009). Diastolic Dysfunction, Cardiovascular Aging, and the Anesthesiologist. Anesthesiology Clinics. 27(3). 497–517. 25 indexed citations
16.
Dudley, Michael. (2003). Resistance Surveillance, Pharmacokinetics/Pharmacodynamics, and Simulation: Can the Use of Old Tools Be Improved to Impact Antibiotic Resistance?. 1 indexed citations
17.
Glinka, Tomasz, Keith Huie, Aesop Cho, et al.. (2003). Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546). Bioorganic & Medicinal Chemistry. 11(4). 591–600. 7 indexed citations
18.
Dudley, Michael. (1995). Bacterial Resistance Mechanisms to β‐Lactam Antibiotics: Assessment of Management Strategies. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(1P2). 3 indexed citations
19.
Viscoli, Claudio, Michael Dudley, Luca Boni, et al.. (1991). Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation. Journal of Antimicrobial Chemotherapy. 27(suppl C). 113–120. 33 indexed citations
20.
Dudley, Michael & Ernest W. Chick. (1964). Corneal Lesions Produced in Rabbits by an Extract of Fusarium Moniliforme. Archives of Ophthalmology. 72(3). 346–350. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marlynne Micalizzi Breakdown of academic impact, for papers by Eun-Hwa Choi Breakdown of academic impact, for papers by Mario Cepparulo Breakdown of academic impact, for papers by Anneke C. Dijkmans Breakdown of academic impact, for papers by Chuanqi Wei Breakdown of academic impact, for papers by V. T. Lolans Breakdown of academic impact, for papers by Olle Aspevall Breakdown of academic impact, for papers by Roopali Sharma Breakdown of academic impact, for papers by Jae‐Cheol Kwon Breakdown of academic impact, for papers by İlknur Erdem
Rankless by CCL
2026